Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UPPROACH: Upfront IMPT and Concurrent Chemotherapy for Endometrial Cancer
NCT04527900Phase 2Terminated
- Sponsor
- University of Maryland, Baltimore
- Start
- Feb 2021
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, Paclitaxel Micelles for Injection in endometrial cancer (EC), sponsored by University of Maryland, Baltimore. Started Feb 2021; status: terminated.
02
Drugs
carboplatinPaclitaxel Micelles for Injection
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT04527900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04527900.